UCB (UCBJY)
(Delayed Data from OTC)
$107.25 USD
+0.88 (0.83%)
Updated Aug 7, 2025 01:14 PM ET
1-Strong Buy of 5 1
B Value C Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
UCBJY 107.25 +0.88(0.83%)
Will UCBJY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for UCBJY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UCBJY
Here's Why Momentum in UCB (UCBJY) Should Keep going
UCB (UCBJY) Upgraded to Strong Buy: What Does It Mean for the Stock?
UCBJY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Could Help UCB (UCBJY) Maintain Its Recent Price Strength
USNA or UCBJY: Which Is the Better Value Stock Right Now?
Other News for UCBJY
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
Bayer Stock Is Soaring Ahead Of Its Earnings Release
UCB's HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa ...
UCB SA (UCBJF) Q2 2025 Earnings Call Transcript
UCB SA 2025 Q2 - Results - Earnings Call Presentation